Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples

Advances in the “omics” field bring about the need for a high number of good quality samples. Many omics studies take advantage of biobanked samples to meet this need. Most of the laboratory errors occur in the pre-analytical phase. Therefore evidence-based standard operating procedures for the pre-analytical phase as well as markers to distinguish between ‘good’ and ‘bad’ quality samples taking into account the desired downstream analysis are urgently needed. We studied concentration changes of metabolites in serum samples due to pre-storage handling conditions as well as due to repeated freeze-thaw cycles. We collected fasting serum samples and subjected aliquots to up to four freeze-thaw cycles and to pre-storage handling delays of 12, 24 and 36 hours at room temperature (RT) and on wet and dry ice. For each treated aliquot, we quantified 127 metabolites through a targeted metabolomics approach. We found a clear signature of degradation in samples kept at RT. Storage on wet ice led to less pronounced concentration changes. 24 metabolites showed significant concentration changes at RT. In 22 of these, changes were already visible after only 12 hours of storage delay. Especially pronounced were increases in lysophosphatidylcholines and decreases in phosphatidylcholines. We showed that the ratio between the concentrations of these molecule classes could serve as a measure to distinguish between ‘good’ and ‘bad’ quality samples in our study. In contrast, we found quite stable metabolite concentrations during up to four freeze-thaw cycles. We concluded that pre-analytical RT handling of serum samples should be strictly avoided and serum samples should always be handled on wet ice or in cooling devices after centrifugation. Moreover, serum samples should be frozen at or below -80°C as soon as possible after centrifugation.

[1]  R. Collins,et al.  Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies. , 2003, International journal of epidemiology.

[2]  Fotini Betsou,et al.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks , 2011, Journal of biomolecular NMR.

[3]  Jerzy Adamski,et al.  Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics , 2011, Metabolomics.

[4]  Joshua LaBaer,et al.  Improving international research with clinical specimens: 5 achievable objectives. , 2012, Journal of proteome research.

[5]  M. Waldenberger,et al.  Comprehensive catalog of European biobanks , 2011, Nature Biotechnology.

[6]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[7]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[8]  Christian Gieger,et al.  On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies , 2012, BMC Bioinformatics.

[9]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[10]  G. Bonsel,et al.  Can whole-blood samples be stored over 24 hours without compromising stability of C-reactive protein, retinol, ferritin, folic acid, and fatty acids in epidemiologic research? , 2005, Clinical chemistry.

[11]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[12]  Kenneth E Blick,et al.  Stability studies of twenty-four analytes in human plasma and serum. , 2002, Clinical chemistry.

[13]  E. Dennis,et al.  Phospholipase A2 Biochemistry , 2009, Cardiovascular Drugs and Therapy.

[14]  Hans-Werner Mewes,et al.  Bioinformatics analysis of targeted metabolomics--uncovering old and new tales of diabetic mice under medication. , 2008, Endocrinology.

[15]  Michael J. Pikal,et al.  Protein Stability During Freezing: Separation of Stresses and Mechanisms of Protein Stabilization , 2007, Pharmaceutical development and technology.

[16]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[17]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[18]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[19]  A. Dirican,et al.  The effect of storage time and freeze-thaw cycles on the stability of serum samples , 2013, Biochemia medica.

[20]  Florian Kronenberg,et al.  Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.

[21]  J. Bruce German,et al.  Effects of sample handling and storage on quantitative lipid analysis in human serum , 2009, Metabolomics.

[22]  S. Narayanan,et al.  The preanalytic phase. An important component of laboratory medicine. , 2000, American journal of clinical pathology.

[23]  Zeper Abliz,et al.  Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers. , 2013, Analytical chemistry.

[24]  Simone Wahl,et al.  Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples , 2014, PloS one.

[25]  Thomas G. Dietterich What is machine learning? , 2020, Archives of Disease in Childhood.

[26]  Richard A. Olshen,et al.  CART: Classification and Regression Trees , 1984 .

[27]  Jan-Eric Litton,et al.  Biobanking for Europe , 2007, Briefings Bioinform..

[28]  R. Collins,et al.  Effect of temperature and light on the stability of fat-soluble vitamins in whole blood over several days: implications for epidemiological studies. , 2004, International journal of epidemiology.

[29]  Alexandros Makriyannis,et al.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters , 2008, Clinical chemistry and laboratory medicine.

[30]  G. Lippi,et al.  Preanalytical variability: the dark side of the moon in laboratory testing , 2006, Clinical chemistry and laboratory medicine.